日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association of bacteriomes with drug susceptibility in lesions of pulmonary tuberculosis patients

肺结核患者病灶内细菌组与药物敏感性的关联

Weili Du, Yingli Zhao, Chen Zhang, Li Zhang, Lijuan Zhou, Zuyu Sun, Xiaojie Huang, Nana Zhang, Zichen Liu, Kun Li, Nanying Che

Utility of Circulating Tumor DNA Assay in Identifying Mutations and Guiding Matched Targeted Therapy in Lung Cancers

循环肿瘤 DNA 检测在肺癌中识别突变和指导匹配靶向治疗的效用

Kun Li, Nana Zhang, Bing Xu, Zichen Liu, Dan Zhao, Yujie Dong, Jing Mu, Haifeng Lin, Guangyu Shan, Sihang Gao, Bo Yu, Xiaoxi Pan, Yanrong Wang, Dongxing Zhang, Nanying Che, Xiaoyong Ji

PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer

PCSK9 调节肺癌免疫检查点疗法的疗效

Xiang Gao ,Ling Yi ,Chang Jiang ,Shuping Li ,Xiaojue Wang ,Bin Yang ,Weiying Li ,Nanying Che ,Jinghui Wang ,Hongtao Zhang ,Shucai Zhang

Bacteriomes in lesions of pulmonary tuberculosis and its association with status of Mycobacterium tuberculosis excretion

肺结核病灶内细菌组学及其与结核分枝杆菌排泄状况的关系

Weili Du, Yingli Zhao, Li Zhang, Jialu Che, Zichen Liu, Kun Li, Nanying Che

Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens

基于扩增子的靶向 NGS 技术在 FFPE 标本耐药结核病诊断中的应用

Jing Song #, Weili Du #, Zichen Liu #, Jialu Che, Kun Li, Nanying Che

Lentiviral vector-based xenograft tumors as candidate reference materials for detection of HER2-low breast cancer

基于慢病毒载体的异种移植瘤作为HER2低乳腺癌检测候选参考材料

Yali Wei, Xu An, Qinmei Cao, Nanying Che, Yuanyuan Xue, Haiteng Deng, Qingtao Wang, Rui Zhou

CD155 expression impairs anti-PD1 therapy response in non-small cell lung cancer

CD155 表达会损害非小细胞肺癌中的抗 PD1 治疗反应

Chang Jiang, Xiaodie Qu, Li Ma, Ling Yi, Xu Cheng, Xiang Gao, Jinghui Wang, Nanying Che, Hongtao Zhang, Shucai Zhang